Month: January 2019
-
Treatment
MannKind is Fixing Foundations to Build a Big Future
Michael is a pharmacist by training and a turnaround expert with a strong record of healthcare innovation. He described the…
Read More » -
Research
T1D Delay/Prevention in at-risk Children
We spoke with Pieter Rottiers, Ph.D., CEO of ActoBio Therapeutics. Genetic testing, combined with existing NIH TrialNet procedures, has shown…
Read More » -
Research
Sernova Cell Pouch Hopes to Improve Islet Transplant Success
Sernova is a regenerative medicine company located in London, Ontario. The corporation is led by President and CEO Dr. Philip…
Read More » -
Living
Gestational DKA in Nepal
We exchanged email with Basanta. “My name is Basanta. I am a 32-year-old woman. I am in Nepal now.…
Read More » -
Living
Yes, Screen your Children for Presymptomatic Diabetes!
We spoke with Marian Rewers, MD, Ph.D., Professor of Pediatrics & Medicine and Executive Director, Barbara Davis Center for Diabetes…
Read More » -
Research
JDRF bets that Pandion Can Help
We spoke with Anthony Coyle, Ph.D., Co-founder and CEO of Pandion Therapeutics which is located in Cambridge Massachusetts. This interview was…
Read More » -
Treatment
Food Effect on Glucose
Modeling Food to Glucose Process Many physiologic processes in the body have been described with a model-based structure. Insulin absorption…
Read More » -
Treatment
A Systems Approach to T1D Care
Diabetes care is especially complex for T2D because there are a lot of variables that impact the effect of food,…
Read More » -
Treatment
Using CGMs, Insulin Pens, and Pumps
How to interpret CGM for BG control Continuous glucose monitors provide a wealth of information that may be used tactically…
Read More » -
Treatment
Bolus Insulin Management in T1D
Bolus insulin is the insulin you take for food What you eat is digested in stages; some is absorbed right…
Read More » -
Treatment
Physiology of Managing T1D
Glucose measurement technology has advanced and this has enabled the control strategies that can be used today. Introduction Our body…
Read More » -
Treatment
Acronyms and References
Acronyms and References amylin https://en.wikipedia.org/wiki/Amylin AndriodAPS https://androidaps.readthedocs.io/en/latest/EN/ Aspart https://en.wikipedia.org/wiki/Insulin_aspart Automated insulin delivery https://diatribe.org/automated-insulin-delivery BG (Blood Glucose) https://en.wikipedia.org/wiki/Blood_sugar_level blood plasma…
Read More » -
Treatment
Basal insulin Management in T1D
Overview The current insulin regimen for glucose management is called basal-bolus, named after its two components: Basal—background insulin reflecting second…
Read More » -
Treatment
My T1D Journey as a Systems Engineer
Systems Education I was always technically inclined, and majored in physics in college, then did graduate work in Cybernetic Systems.…
Read More » -
Treatment
Dexcom is Excited, and Best is yet to Come
How do you see CGM devices evolving? The foundation of our product development is that we want our products to:…
Read More » -
Research
Vaccine for T1D in Clinical Trials Soon
INTRODUCTION Virus infections have long been considered as a possible cause of type 1 diabetes. One virus group, enteroviruses (EVs),…
Read More » -
Research
Regrowth of Human Beta Cells for T1D and T2D
Effective Therapeutic Rate A combination of two drugs enhances the production of beta cells such that they proliferate at the…
Read More » -
Treatment
